These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29446997)
1. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma. Zhu R; Weng D; Lu S; Lin D; Wang M; Chen D; Lv J; Li H; Lv F; Xi L; Zhou J; Ma D; Li N Hum Gene Ther; 2018 Feb; 29(2):251-258. PubMed ID: 29446997 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma. Li N; Zhou J; Weng D; Zhang C; Li L; Wang B; Song Y; He Q; Lin D; Chen D; Chen G; Gao Q; Wang S; Xu G; Meng L; Lu Y; Ma D Clin Cancer Res; 2007 Oct; 13(19):5847-54. PubMed ID: 17908978 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model. Zhu R; Chen D; Lin D; Lu F; Yin J; Li N Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model. Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830 [TBL] [Abstract][Full Text] [Related]
5. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]
6. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model. Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma. Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896 [TBL] [Abstract][Full Text] [Related]
8. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53. Liu X; Wang S; Guo X; Wei F; Yin J; Zang Y; Li N; Chen D Oncotarget; 2016 Apr; 7(14):18896-905. PubMed ID: 26934443 [TBL] [Abstract][Full Text] [Related]
9. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene. Li BJ; Zhang C; Yi YX; Hao Y; Liu XP; Ou QJ World J Gastroenterol; 2007 Aug; 13(29):4006-10. PubMed ID: 17663519 [TBL] [Abstract][Full Text] [Related]
10. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518 [TBL] [Abstract][Full Text] [Related]
11. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma. Qian C; Idoate M; Bilbao R; Sangro B; Bruña O; Vázquez J; Prieto J Hum Gene Ther; 1997 Feb; 8(3):349-58. PubMed ID: 9048202 [TBL] [Abstract][Full Text] [Related]
12. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376 [TBL] [Abstract][Full Text] [Related]
14. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Herman JR; Adler HL; Aguilar-Cordova E; Rojas-Martinez A; Woo S; Timme TL; Wheeler TM; Thompson TC; Scardino PT Hum Gene Ther; 1999 May; 10(7):1239-49. PubMed ID: 10340555 [TBL] [Abstract][Full Text] [Related]
15. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors. Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470 [TBL] [Abstract][Full Text] [Related]
16. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium]. Wang B; Weng J Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913 [TBL] [Abstract][Full Text] [Related]
17. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Freund CT; Tong XW; Rowley D; Engehausen D; Frolov A; Kieback DG; Lerner SP Urol Oncol; 2003; 21(3):197-205. PubMed ID: 12810206 [TBL] [Abstract][Full Text] [Related]
18. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model]. Zhou JF; Chen G; Lu YP; Wang SX; Ma D Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):68-70. PubMed ID: 15059319 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736 [TBL] [Abstract][Full Text] [Related]